On February 24, Ukraine launched an active vaccination with a Covishield certified preparation produced under the AstraZeneca license.On February 24, Ukraine launched an active vaccination with a Covishield certified preparation produced under the AstraZeneca license.
Vaccination is designed for 5 stages: the first group, priority — people with the highest risk of infection and development COVID-19 and those who perform critical functions in the fight against the pandemic (367 thousand people), fifth — after the implementation of 1–4 stages and in the conditions of high availability of vaccines — adults from 18 years, which have not entered priority groups (13.1 million people).
As of today, Ukraine has moved to the second phase of the all-Ukrainian vaccination. Also, Ukraine has entered into additional direct agreements with the Indian Serum Institute for the supply of vaccines developed by AstraZeneca and American NovaVax.
